
Synlogic, Inc. (SYBX) Dividend History
Synlogic, Inc. is a clinical-stage biopharmaceutical company focused on developing synthetic biotic medicines—engineered live bacteria designed to treat various diseases. Utilizing proprietary synthetic biology platforms, the company aims to create innovative therapies for conditions such as metabolic disorders, inflammation, and other serious health issues.
Dividend History
Synlogic, Inc. currently does not pay dividends
Company News
-
GlobeNewswire Inc.
-
Zacks Investment Research
-
Zacks Investment Research
-
GlobeNewswire Inc.